StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Dare Bioscience's market cap was $10.53M on Nov 11, 2026, against $25.63M a year earlier. Over the last 5 years it ranged from $10.53M to $427.65M, with a median of $34.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.53M-60.8%
2025Dec 31, 2025$26.88M+0.8%
2024Dec 31, 2024$26.66M-12.2%
2023Dec 29, 2023$30.37M-56.4%
2022Dec 30, 2022$69.68M-54.5%
2021Dec 31, 2021$153.21M+240.2%
2020Dec 31, 2020$45.03M+229.1%
2019Dec 31, 2019$13.68M+68.6%
2018Dec 31, 2018$8.12M-38.0%
2017Dec 29, 2017$13.09M-32.5%
2016Dec 30, 2016$19.39M-74.7%
2015Dec 31, 2015$76.57M-38.8%
2014Dec 31, 2014$125.18M–

More Dare Bioscience figures

See a number that looks wrong?